MXPA03007881A - Bacterias productoras de acido lactico para tratar y prevenir la alergia. - Google Patents

Bacterias productoras de acido lactico para tratar y prevenir la alergia.

Info

Publication number
MXPA03007881A
MXPA03007881A MXPA03007881A MXPA03007881A MXPA03007881A MX PA03007881 A MXPA03007881 A MX PA03007881A MX PA03007881 A MXPA03007881 A MX PA03007881A MX PA03007881 A MXPA03007881 A MX PA03007881A MX PA03007881 A MXPA03007881 A MX PA03007881A
Authority
MX
Mexico
Prior art keywords
agents
treating
lactic acid
acid bacteria
preventing allergy
Prior art date
Application number
MXPA03007881A
Other languages
English (en)
Inventor
Rodolphe Fritsche
Original Assignee
Nestle Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestle Sa filed Critical Nestle Sa
Publication of MXPA03007881A publication Critical patent/MXPA03007881A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/42—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins
    • C07K16/4283—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig
    • C07K16/4291—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against immunoglobulins against an allotypic or isotypic determinant on Ig against IgE
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
    • A61K2039/523—Bacterial cells; Fungal cells; Protozoal cells expressing foreign proteins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/54—Medicinal preparations containing antigens or antibodies characterised by the route of administration
    • A61K2039/541—Mucosal route
    • A61K2039/542—Mucosal route oral/gastrointestinal

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Polymers & Plastics (AREA)
  • Biochemistry (AREA)
  • Microbiology (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Animal Husbandry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Biophysics (AREA)
  • Food Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Wood Science & Technology (AREA)
  • Birds (AREA)
  • Pulmonology (AREA)
  • Rheumatology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Pain & Pain Management (AREA)
  • General Engineering & Computer Science (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
MXPA03007881A 2001-03-02 2002-03-04 Bacterias productoras de acido lactico para tratar y prevenir la alergia. MXPA03007881A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP01105138A EP1239032A1 (en) 2001-03-02 2001-03-02 Lactic acid bacteria as agents for treating and preventing allergy
PCT/EP2002/002326 WO2002086102A1 (en) 2001-03-02 2002-03-04 Lactic acid bacteria as agents for treating and preventing allergy

Publications (1)

Publication Number Publication Date
MXPA03007881A true MXPA03007881A (es) 2003-12-04

Family

ID=8176657

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA03007881A MXPA03007881A (es) 2001-03-02 2002-03-04 Bacterias productoras de acido lactico para tratar y prevenir la alergia.

Country Status (17)

Country Link
US (1) US7235395B2 (es)
EP (2) EP1239032A1 (es)
JP (1) JP2004528034A (es)
KR (2) KR20080111172A (es)
CN (1) CN1505678A (es)
AR (1) AR035761A1 (es)
AU (1) AU2002256639B2 (es)
BR (1) BR0207749A (es)
CA (1) CA2438833A1 (es)
IL (1) IL157468A0 (es)
MX (1) MXPA03007881A (es)
NO (1) NO20033796L (es)
NZ (1) NZ527861A (es)
PL (1) PL367208A1 (es)
RU (1) RU2312892C2 (es)
WO (1) WO2002086102A1 (es)
ZA (1) ZA200307680B (es)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004112773A1 (fr) * 2003-04-24 2004-12-29 Shin-Jen Shiao Compositions pharmaceutiques utilisees pour le traitement de maladie immune et amelioration
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US7955834B2 (en) 2004-06-03 2011-06-07 Biogaia Ab Method for improved breast milk feeding to reduce the risk of allergy
US7862808B2 (en) * 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
US8252314B2 (en) 2004-09-24 2012-08-28 Hill's Pet Nutrition, Inc. Hypoallergenic composition
KR101260533B1 (ko) 2005-03-03 2013-05-06 가부시키가이샤 메이지 면역기능 조정제
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US7303745B2 (en) * 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
CA2607949C (en) 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
EP2261323A1 (en) 2005-05-31 2010-12-15 The Iams Company Feline probiotic lactobacilli
JP2007300849A (ja) * 2006-05-11 2007-11-22 Oji Paper Co Ltd ペットフード
CA2673465A1 (en) 2007-02-01 2008-08-07 The Iams Company Method for decreasing inflammation and stress in a mammal
CN102028224B (zh) * 2007-06-21 2012-12-26 东宇生物科技股份有限公司 抗过敏的乳酸菌
KR100913405B1 (ko) * 2008-03-25 2009-08-21 광주과학기술원 Ｔｈ２－매개 면역 질환의 예방 또는 치료용 조성물
JP5150722B2 (ja) 2008-04-25 2013-02-27 亀田製菓株式会社 抗アレルギー作用を有する新規乳酸菌と、該乳酸菌を含む抗アレルギー剤、食品及び医薬品組成物と、前記抗アレルギー剤の製造方法
US9771199B2 (en) * 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
MX2011002080A (es) * 2008-09-04 2011-03-29 Om Pharma Extractos inmunomoduladores de bacteria de lactobacillus y metodos de manufactura y uso de los mismos.
US20100055082A1 (en) * 2008-09-04 2010-03-04 Jacques Alain Bauer Immunomodulatory extracts from lactobacillus bacteria and methods of manufacturing and use thereof
CA2761444C (en) * 2009-05-11 2018-04-24 Nestec S.A. Lactobacillus johnsonii la1 ncc533 (cncm i-1225) and immune disorders
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
PL2467031T3 (pl) 2009-08-18 2015-03-31 Nestec Sa Odżywcza kompozycja zawierająca szczepy lactococcus i zmniejszająca objawy alergiczne, zwłaszcza dla małych dzieci i dzieci
CN102958604A (zh) 2010-07-09 2013-03-06 住友化学株式会社 生产烯烃氧化物的方法
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
BR112020013818A2 (pt) * 2018-01-12 2020-12-01 Gi Innovation, Inc. composição compreendendo probióticos e polipeptídeo com afinidade de ligação para ige e uso dos mesmos
WO2024081219A1 (en) 2022-10-14 2024-04-18 Csp Technologies, Inc. Container and method for storing and stabilizing moisture sensitive products

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5242821A (en) 1989-07-10 1993-09-07 Valio, Finnish Co-Operative Dairies' Association Lactococcus promoter and signal sequences for expression in bacteria
GB9006400D0 (en) 1990-03-22 1990-05-23 Ciba Geigy Ag Bacterial vectors
US6737521B1 (en) * 1990-05-11 2004-05-18 The Rockefeller University Delivery and expression of a hybrid surface protein on the surface of gram positive bacteria
EP0550428A1 (en) 1990-08-30 1993-07-14 Genesit Oy Promoter probe vectors, able to replicate in e.coli, b.subtilis, lactococci and lactobacillus as well as uses thereof
GB9125695D0 (en) 1991-12-03 1992-01-29 Mastavac Limited Medical preparations
GB9400650D0 (en) * 1994-01-14 1994-03-09 Smithkline Beecham Biolog Expression of surface lazer proteins
AU2149495A (en) 1995-04-11 1996-10-30 Nederlandse Organisatie Voor Toegepast- Natuurwetenschappelijk Onderzoek Tno Method for the construction of vectors for lactic acid bacte ria like lactobacillus such that the bacteria can efficientl y express, secrete and display proteins at the surface
GB9518323D0 (en) 1995-09-07 1995-11-08 Steidler Lothar Materials and methods relating to the attachment and display of substances on cell surfaces
HUP9901109A3 (en) * 1996-03-01 1999-11-29 Novartis Ag Peptide immunogens for vaccination against and treatment of allergy
JPH09234078A (ja) 1996-03-04 1997-09-09 Meiji Milk Prod Co Ltd 乳酸菌用分泌ベクター及び該ベクターを用いたタンパク質の製造方法
WO1998010079A1 (en) 1996-09-06 1998-03-12 Bioteknologisk Institut A lactic acid bacterial regulatable expression system
US6642011B2 (en) * 1998-04-15 2003-11-04 Genencor International, Inc. Human protease and use of such protease for pharmaceutical applications and for reducing the allergenicity of non-human proteins
US6835550B1 (en) * 1998-04-15 2004-12-28 Genencor International, Inc. Mutant proteins having lower allergenic response in humans and methods for constructing, identifying and producing such proteins
GB9908533D0 (en) * 1999-04-14 1999-06-09 Novartis Ag Organic compounds
IL154284A0 (en) * 2000-09-25 2003-09-17 Nestle Sa Lactic acid bacteria capable of reducing an individual's tendency to develop allergic reactions
WO2002033109A2 (en) * 2000-10-20 2002-04-25 Bioteknologisk Institut Fermentation method for production of heterologous gene products in lactic acid bacteria
AU1120102A (en) * 2000-11-02 2002-05-15 Univ Singapore AopB gene, protein, homologs, fragments and variants thereof, and their use for cell surface display

Also Published As

Publication number Publication date
JP2004528034A (ja) 2004-09-16
KR20080111172A (ko) 2008-12-22
EP1239032A1 (en) 2002-09-11
CA2438833A1 (en) 2002-10-31
PL367208A1 (en) 2005-02-21
NZ527861A (en) 2005-02-25
NO20033796L (no) 2003-10-31
AR035761A1 (es) 2004-07-07
CN1505678A (zh) 2004-06-16
ZA200307680B (en) 2005-01-13
KR20030082950A (ko) 2003-10-23
BR0207749A (pt) 2004-06-01
RU2003129265A (ru) 2005-04-10
AU2002256639B2 (en) 2006-10-19
US7235395B2 (en) 2007-06-26
WO2002086102A1 (en) 2002-10-31
NO20033796D0 (no) 2003-08-26
US20040265290A1 (en) 2004-12-30
EP1370640A1 (en) 2003-12-17
IL157468A0 (en) 2004-03-28
RU2312892C2 (ru) 2007-12-20

Similar Documents

Publication Publication Date Title
MXPA03007881A (es) Bacterias productoras de acido lactico para tratar y prevenir la alergia.
GB0512558D0 (en) Microorganisms for well treatment
MX236443B (es) Combinacion de bacterias de acido lactico y su uso para la prevencion y/o tratamiento de infecciones y condiciones inflamatorias.
IL159839A (en) Pyrazolylcarboxanilides, process for their preparation and their use for controlling undesired microorganisms
MXPA03007816A (es) Calzoncillo desechable y metodo para proporcionar el mismo.
GB0110288D0 (en) Composition and treatment method
HK1061212A1 (en) Pyranoindazoles and their use for the treatment ofglaucoma
ZA200306232B (en) Treatment involving DKK-1 or antagonists thereof.
AU2002367023A8 (en) Compositions and methods for treating heart failure
EP1461047A4 (en) COMPOSITIONS AND METHODS FOR TREATING ANIMALS
WO2003063725A3 (en) Methods of preventing and treating flavivirus infection in animals
AU2002365057A8 (en) Compositions and methods for treating heart failure
AP2002002483A0 (en) Lactic acid bacteria for the treatment and/or prophylaxix of giardasis
MXPA02009342A (es) Uso de bacterias de acido lactico para el tratamiento de la peritonitis.
AU2003239132A8 (en) Methods and compositions for preventing and treating microbial infections
HUP0401913A3 (en) Medicine for preventing and treating bromhidrosis
AU2002349268A1 (en) Medicine for preventing and treating bromidrosis
EP1481691A4 (en) STERILIZER AND STERILIZATION METHOD
AU2003259202A8 (en) Compositions and methods for treating and preventing infection
AP2004002962A0 (en) Adaptation of bacteria for use in leaching.
AU2003258176A8 (en) Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases
ZA200201513B (en) Treatment of nitriles with glycolic acid.
ZA200204018B (en) Combination treatment for depression and anxiety.
AU2002223305A1 (en) Preserving with lactic acid bacteria
AU2003258177A8 (en) Compounds, compositions and methods for treating or preventing pneumovirus infection and associated diseases

Legal Events

Date Code Title Description
FA Abandonment or withdrawal